^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
Title:

TIMP-2 as a predictive biomarker in 5-Fu-resistant colorectal cancer

Published date:
03/11/2023
Excerpt:
...the patient-derived xenograft (PDX) model of 5-Fu resistance was used to evaluate the feasibility of TIMP-2 as a predictive biomarker of 5-Fu resistance….Our experimental results display that TIMP-2 expression is elevated in colorectal cancer drug-resistant cell lines, and its expression level is closely related to 5-Fu resistance.
DOI:
10.1007/s00432-023-04670-w